Pfizer (PFE) Divestments (2012 - 2025)
Pfizer (PFE) reported Divestments of -$6.3 billion for Q3 2025, down 280.46% year-over-year from $3.5 billion in Q3 2024, and down 200.0% on a QoQ basis from $6.3 billion in Q2 2025.
Pfizer (PFE) has 6 years of Divestments data on file, last reported at -$6.3 billion in Q3 2025.
- Quarterly Divestments fell 280.46% year-over-year to -$6.3 billion in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 billion (changed N/A YoY) and the FY2025 annual result came in at $6.3 billion, down 10.36% from the prior year.
- Divestments slipped to -$6.3 billion in Q3 2025 per PFE's latest filing, from $6.3 billion in the prior quarter.
- Across five years, Divestments topped out at $6.3 billion in Q1 2025 and bottomed at -$6.3 billion in Q3 2025.
- The 4-year median for Divestments is $3.5 billion (2024), against an average of $2.5 billion.
- The widest annual swing landed in 2021, when Divestments soared 99.97%; it then tumbled 280.46% in 2025.
- Tracing PFE's Divestments over 4 years: stood at -$3.0 million in 2021, then soared by 132100.0% to $4.0 billion in 2022, then declined by 11.84% to $3.5 billion in 2024, then plunged by 280.46% to -$6.3 billion in 2025.
- Per Business Quant, the three latest PFE Divestments figures stand at -$6.3 billion (Q3 2025), $6.3 billion (Q2 2025), and $6.3 billion (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 312.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 28, 2025 | -6.30 Bn |
| Jun 29, 2025 | 6.30 Bn |
| Mar 30, 2025 | 6.31 Bn |
| Sep 29, 2024 | 3.49 Bn |
| Mar 31, 2024 | 3.49 Bn |
| Oct 2, 2022 | 3.96 Bn |
| Jul 4, 2021 | -3.00 Mn |
| Sep 27, 2020 | -11.47 Bn |
| Jun 28, 2020 | -11.43 Bn |
| Mar 29, 2020 | -19.00 Mn |
| Dec 31, 2012 | 11.85 Bn |